Haploinsufficiency of the Sin3/HDAC corepressor complex member SIN3B causes a syndromic intellectual disability/autism spectrum disorder.


Journal

American journal of human genetics
ISSN: 1537-6605
Titre abrégé: Am J Hum Genet
Pays: United States
ID NLM: 0370475

Informations de publication

Date de publication:
06 05 2021
Historique:
received: 23 09 2019
accepted: 18 03 2021
pubmed: 4 4 2021
medline: 1 7 2021
entrez: 3 4 2021
Statut: ppublish

Résumé

Proteins involved in transcriptional regulation harbor a demonstrated enrichment of mutations in neurodevelopmental disorders. The Sin3 (Swi-independent 3)/histone deacetylase (HDAC) complex plays a central role in histone deacetylation and transcriptional repression. Among the two vertebrate paralogs encoding the Sin3 complex, SIN3A variants cause syndromic intellectual disability, but the clinical consequences of SIN3B haploinsufficiency in humans are uncharacterized. Here, we describe a syndrome hallmarked by intellectual disability, developmental delay, and dysmorphic facial features with variably penetrant autism spectrum disorder, congenital malformations, corpus callosum defects, and impaired growth caused by disruptive SIN3B variants. Using chromosomal microarray or exome sequencing, and through international data sharing efforts, we identified nine individuals with heterozygous SIN3B deletion or single-nucleotide variants. Five individuals harbor heterozygous deletions encompassing SIN3B that reside within a ∼230 kb minimal region of overlap on 19p13.11, two individuals have a rare nonsynonymous substitution, and two individuals have a single-nucleotide deletion that results in a frameshift and predicted premature termination codon. To test the relevance of SIN3B impairment to measurable aspects of the human phenotype, we disrupted the orthologous zebrafish locus by genome editing and transient suppression. The mutant and morphant larvae display altered craniofacial patterning, commissural axon defects, and reduced body length supportive of an essential role for Sin3 function in growth and patterning of anterior structures. To investigate further the molecular consequences of SIN3B variants, we quantified genome-wide enhancer and promoter activity states by using H3K27ac ChIP-seq. We show that, similar to SIN3A mutations, SIN3B disruption causes hyperacetylation of a subset of enhancers and promoters in peripheral blood mononuclear cells. Together, these data demonstrate that SIN3B haploinsufficiency leads to a hitherto unknown intellectual disability/autism syndrome, uncover a crucial role of SIN3B in the central nervous system, and define the epigenetic landscape associated with Sin3 complex impairment.

Identifiants

pubmed: 33811806
pii: S0002-9297(21)00101-4
doi: 10.1016/j.ajhg.2021.03.017
pmc: PMC8206166
pii:
doi:

Substances chimiques

Histones 0
Repressor Proteins 0
SIN3B protein, human 0
Zebrafish Proteins 0
sin3b protein, zebrafish 0
Histone Deacetylases EC 3.5.1.98

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

929-941

Subventions

Organisme : NICHD NIH HHS
ID : R01 HD096326
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH106826
Pays : United States

Informations de copyright

Copyright © 2021 American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Références

Cell Rep. 2018 Dec 4;25(10):2797-2807.e8
pubmed: 30517867
J Neurophysiol. 2017 Aug 1;118(2):755-770
pubmed: 28490640
Eur J Cell Biol. 2013 Aug-Sep;92(8-9):237-46
pubmed: 24189169
J Vis Exp. 2013 Aug 24;(78):e50338
pubmed: 23995499
Nature. 2015 Feb 19;518(7539):317-30
pubmed: 25693563
Nat Genet. 2000 Jun;25(2):205-8
pubmed: 10835638
Eur J Hum Genet. 2013 Jul;21(7):743-8
pubmed: 23188045
Proc Natl Acad Sci U S A. 2009 May 12;106(19):7876-81
pubmed: 19380719
Am J Hum Genet. 2019 May 2;104(5):990-993
pubmed: 31006510
Am J Hum Genet. 2015 Dec 3;97(6):790-800
pubmed: 26637975
Genome Res. 2015 Oct;25(10):1473-81
pubmed: 26430157
PLoS One. 2012;7(11):e47394
pubmed: 23155370
Eur J Med Genet. 2011 Sep-Oct;54(5):e501-4
pubmed: 21700002
Mol Cell Biol. 2002 Apr;22(8):2743-50
pubmed: 11909966
Nature. 1998 May 28;393(6683):386-9
pubmed: 9620804
Nat Genet. 2017 Feb;49(2):238-248
pubmed: 28067909
Am J Hum Genet. 2015 May 7;96(5):784-96
pubmed: 25937446
J Biol Chem. 2000 Mar 31;275(13):9461-7
pubmed: 10734093
Am J Hum Genet. 2019 Jun 6;104(6):1073-1087
pubmed: 31079899
J Med Genet. 2012 Aug;49(8):539-43
pubmed: 22889856
Am J Hum Genet. 2019 May 2;104(5):985-989
pubmed: 31006513
J Med Genet. 2017 Jul;54(7):490-501
pubmed: 28264986
Cell. 1999 Nov 24;99(5):447-50
pubmed: 10589671
Mol Syndromol. 2016 Oct;7(5):262-273
pubmed: 27867341
Am J Med Genet A. 2009 May;149A(5):975-81
pubmed: 19353584
Am J Hum Genet. 2016 Dec 1;99(6):1338-1352
pubmed: 27839872
Cell. 2016 Nov 17;167(5):1385-1397.e11
pubmed: 27863250
Cell. 1997 May 2;89(3):357-64
pubmed: 9150135
Nature. 2016 Aug 17;536(7616):285-91
pubmed: 27535533
Am J Hum Genet. 2013 Feb 7;92(2):210-20
pubmed: 23332918
Am J Hum Genet. 2017 Feb 2;100(2):352-363
pubmed: 28132691
Nature. 2012 Sep 13;489(7415):313-7
pubmed: 22885700
Nature. 2012 Sep 6;489(7414):57-74
pubmed: 22955616
Nat Genet. 2011 Mar;43(3):197-203
pubmed: 21258343
Am J Hum Genet. 2017 Oct 5;101(4):503-515
pubmed: 28942966
Curr Opin Neurol. 2014 Apr;27(2):149-56
pubmed: 24565942
Dev Dyn. 2017 Nov;246(11):946-955
pubmed: 28850761
Nat Biotechnol. 2013 Jul;31(7):615-22
pubmed: 23770639
Am J Med Genet A. 2014 Jul;164A(7):1826-9
pubmed: 24715439
Hum Mutat. 2015 Oct;36(10):928-30
pubmed: 26220891
Nat Neurosci. 2018 Nov;21(11):1618-1627
pubmed: 30349106
Mol Cell. 2008 Nov 7;32(3):359-70
pubmed: 18995834
Cell. 1997 May 2;89(3):349-56
pubmed: 9150134
Am J Hum Genet. 2020 Jul 2;107(1):164-172
pubmed: 32553196
J Med Genet. 2017 Feb;54(2):87-92
pubmed: 27620904
Proc Natl Acad Sci U S A. 2008 Mar 18;105(11):4168-72
pubmed: 18332431
Nat Genet. 2016 Aug;48(8):877-87
pubmed: 27399968
Clin Genet. 2019 Feb;95(2):231-240
pubmed: 29672823
Prog Mol Biol Transl Sci. 2014;128:139-76
pubmed: 25410544

Auteurs

Xenia Latypova (X)

Service de Génétique Médicale, CHU Nantes, 9 quai Moncousu, 44093 Nantes Cedex 1, France; Center for Human Disease Modeling, Duke University Medical Center, Durham, NC 27701, USA; L'Institut du Thorax, INSERM, CNRS, Université de Nantes, 44007 Nantes, France.

Marie Vincent (M)

Service de Génétique Médicale, CHU Nantes, 9 quai Moncousu, 44093 Nantes Cedex 1, France; L'Institut du Thorax, INSERM, CNRS, Université de Nantes, 44007 Nantes, France.

Alice Mollé (A)

Université de Nantes, CHU Nantes, Inserm, Centre de Recherche en Transplantation et Immunologie, UMR 1064, ITUN, 44000 Nantes, France.

Oluwadamilare A Adebambo (OA)

Center for Human Disease Modeling, Duke University Medical Center, Durham, NC 27701, USA.

Cynthia Fourgeux (C)

Université de Nantes, CHU Nantes, Inserm, Centre de Recherche en Transplantation et Immunologie, UMR 1064, ITUN, 44000 Nantes, France.

Tahir N Khan (TN)

Center for Human Disease Modeling, Duke University Medical Center, Durham, NC 27701, USA; Department of Biological Sciences, National University of Medical Sciences, 46000 Rawalpindi, Pakistan.

Alfonso Caro (A)

Unidad de Genética, Grupo de Investigación Traslacional en Genética, Hospital Universitario y Politécnico La Fe, 46026 Valencia, Spain.

Monica Rosello (M)

Unidad de Genética, Grupo de Investigación Traslacional en Genética, Hospital Universitario y Politécnico La Fe, 46026 Valencia, Spain.

Carmen Orellana (C)

Unidad de Genética, Grupo de Investigación Traslacional en Genética, Hospital Universitario y Politécnico La Fe, 46026 Valencia, Spain.

Dmitriy Niyazov (D)

Department of Pediatrics, Ochsner Clinic, New Orleans, LA 70128, USA.

Damien Lederer (D)

Centre de Génétique Humaine, IPG, 6041 Gosselies, Belgium.

Marie Deprez (M)

Service de Neuropédiatrie, Clinique Saint Elizabeth, 5000 Namur, Belgium.

Yline Capri (Y)

Service de Génétique Médicale, Hôpital Robert Debré, 75019 Paris, France.

Peter Kannu (P)

Division of Clinical and Metabolic Genetics, The Hospital for Sick Children, Toronto, ON M5G 1X8, Canada.

Anne Claude Tabet (AC)

Service de Cytogénétique, Hôpital Robert Debré, 75019 Paris, France.

Jonathan Levy (J)

Service de Cytogénétique, Hôpital Robert Debré, 75019 Paris, France.

Emmelien Aten (E)

Department of Clinical Genetics, Leiden University Medical Center, 2333 Leiden, the Netherlands.

Nicolette den Hollander (N)

Department of Clinical Genetics, Leiden University Medical Center, 2333 Leiden, the Netherlands.

Miranda Splitt (M)

Northern Genetics Service, Institute of Genetic Medicine, Newcastle Upon Tyne NE1 3BZ, UK.

Jagdeep Walia (J)

Kingston General Hospital Research Institute, 76 Stuart Street, Kingston, ON K7L 2V7, Canada.

Ladonna L Immken (LL)

Clinical Genetics, Dell Children's Medical Group, Austin, TX 78731, USA.

Pawel Stankiewicz (P)

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.

Kirsty McWalter (K)

GeneDx, 207 Perry Parkway, Gaithersburg, MD 20877, USA.

Sharon Suchy (S)

GeneDx, 207 Perry Parkway, Gaithersburg, MD 20877, USA.

Raymond J Louie (RJ)

Greenwood Genetic Center, 106 Gregor Mendel Cir, Greenwood, SC 29646, USA.

Shannon Bell (S)

Greenwood Genetic Center, 106 Gregor Mendel Cir, Greenwood, SC 29646, USA.

Roger E Stevenson (RE)

Greenwood Genetic Center, 106 Gregor Mendel Cir, Greenwood, SC 29646, USA.

Justine Rousseau (J)

Sainte-Justine Hospital, 3175, Cote-Sainte-Catherine, Montreal, QC, Canada.

Catherine Willem (C)

Etablissement Français du Sang, 44000 Nantes, France.

Christelle Retiere (C)

Etablissement Français du Sang, 44000 Nantes, France; CRCINA, INSERM, CNRS, Université d'Angers, Université de Nantes, 44000 Nantes, France; LabEx IGO, Nantes 44000, France.

Xiang-Jiao Yang (XJ)

Rosalind & Morris Goodman Cancer Research Center and Department of Medicine, McGill University, Montreal, QC H3A 1A3, Canada.

Philippe M Campeau (PM)

Sainte-Justine Hospital, 3175, Cote-Sainte-Catherine, Montreal, QC, Canada.

Francisco Martinez (F)

Unidad de Genética, Grupo de Investigación Traslacional en Genética, Hospital Universitario y Politécnico La Fe, 46026 Valencia, Spain.

Jill A Rosenfeld (JA)

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.

Cédric Le Caignec (C)

Service de Génétique Médicale, CHU Nantes, 9 quai Moncousu, 44093 Nantes Cedex 1, France; L'Institut du Thorax, INSERM, CNRS, Université de Nantes, 44007 Nantes, France.

Sébastien Küry (S)

Service de Génétique Médicale, CHU Nantes, 9 quai Moncousu, 44093 Nantes Cedex 1, France; L'Institut du Thorax, INSERM, CNRS, Université de Nantes, 44007 Nantes, France.

Sandra Mercier (S)

Service de Génétique Médicale, CHU Nantes, 9 quai Moncousu, 44093 Nantes Cedex 1, France; L'Institut du Thorax, INSERM, CNRS, Université de Nantes, 44007 Nantes, France.

Kamran Moradkhani (K)

Service de Génétique Médicale, CHU Nantes, 9 quai Moncousu, 44093 Nantes Cedex 1, France.

Solène Conrad (S)

Service de Génétique Médicale, CHU Nantes, 9 quai Moncousu, 44093 Nantes Cedex 1, France.

Thomas Besnard (T)

Service de Génétique Médicale, CHU Nantes, 9 quai Moncousu, 44093 Nantes Cedex 1, France; L'Institut du Thorax, INSERM, CNRS, Université de Nantes, 44007 Nantes, France.

Benjamin Cogné (B)

Service de Génétique Médicale, CHU Nantes, 9 quai Moncousu, 44093 Nantes Cedex 1, France; L'Institut du Thorax, INSERM, CNRS, Université de Nantes, 44007 Nantes, France.

Nicholas Katsanis (N)

Center for Human Disease Modeling, Duke University Medical Center, Durham, NC 27701, USA; Advanced Center for Translational and Genetic Medicine, Stanley Manne Children's Research Institute, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL 60611, USA; Department of Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.

Stéphane Bézieau (S)

Service de Génétique Médicale, CHU Nantes, 9 quai Moncousu, 44093 Nantes Cedex 1, France; L'Institut du Thorax, INSERM, CNRS, Université de Nantes, 44007 Nantes, France.

Jeremie Poschmann (J)

Université de Nantes, CHU Nantes, Inserm, Centre de Recherche en Transplantation et Immunologie, UMR 1064, ITUN, 44000 Nantes, France. Electronic address: jeremie.poschmann@univ-nantes.fr.

Erica E Davis (EE)

Advanced Center for Translational and Genetic Medicine, Stanley Manne Children's Research Institute, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL 60611, USA; Department of Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA. Electronic address: eridavis@luriechildrens.org.

Bertrand Isidor (B)

Service de Génétique Médicale, CHU Nantes, 9 quai Moncousu, 44093 Nantes Cedex 1, France; L'Institut du Thorax, INSERM, CNRS, Université de Nantes, 44007 Nantes, France. Electronic address: bertrand.isidor@chu-nantes.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH